Description

Sustiva is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) approved by the U.S. Food and Drug Administration for HIV-1-positive adults and children older than 3 years of age.  For patients beginning antiretroviral…

A recent report based on a survey by UNAIDS and the World Bank revealed the negative effects of the global economic crisis on HIV/AIDS treatment and prevention programs worldwide. Of the 71 countries surveyed in March, 34 countries, which comprise 75 percent of people living with HIV, reported the economic conditions had already impacted prevention programs that focus on high-risk groups including sex workers, people who inject drugs, and men who have sex with men.

With global markets worsening, local…

Description

Fuzeon is the first fusion inhibitor approved by the U.S. Food and Drug Administration for patients who…

A recent study presented at the annual American Society of Gene Therapy (ASGT) meeting found that hematopoietic (blood) stem cell therapy was promising in the management and treatment of HIV and AIDS.

Geoff Symonds, one of the authors of the study and now Chief Scientific Officer of Calimmune, Inc., said his research while at Johnson & Johnson and Calimmune — which involves the therapeutic use of hematopoietic stem cells with protective genes — has the potential to safely and effectively…

A recently developed contraceptive ring may not only prevent pregnancy, but also protect women from contracting HIV, says a new study featured in the May issue of the journal AIDS.

Researchers from the Weill Cornell Medical College in New York are studying the effectiveness of a vaginal ring that uses anti-HIV chemicals and other natural materials already approved by the U.S. Food and Drug Administration.

The chemicals in the ring, which disable sperm and disrupt numerous stages in the…